Gelesis Holdings, Inc.
Gelesis Holdings, Inc. (GLSHQ) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GLSHQ · as of Jun 9, 2026
Key Statistics
Explore Gelesis Holdings, Inc. Data
glshq stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
glshq competitorsGLSHQ
CRXM
CRYO
EPRSQ
EQUR
FPSUFStock Performance
Full HistoryAbout Gelesis Holdings, Inc.
Gelesis Holdings, Inc. operated as a commercial-stage biotherapeutics company, concentrating on the development of biomimetic solutions. Its core mission revolved around addressing the root causes of …
what is gelesis holdings, inc. · glshq stock overview · gelesis holdings, inc. company profile · who is gelesis holdings, inc. ceo · glshq OTC · gelesis holdings, inc. headquarters · gelesis holdings, inc. business segments
About Stock Overview & Key Data
Gelesis Holdings, Inc. (GLSHQ) is a Healthcare company in the Biotechnology industry, listed on OTC since Aug 24, 2020. As of the latest trading session, GLSHQ stock price is $0.00, with a market capitalization of $7,334. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
In fiscal year 2022, Gelesis Holdings, Inc. reported revenue of $25.8M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Gelesis Holdings, Inc. (GLSHQ) stock price is $0.00. The stock is traded on OTC under the ticker symbol GLSHQ. The 52-week range is $0.00 – $0.01.